NCT02316002 · Interventional trial
Phase II Study of Pembrolizumab After Curative Intent Treatment for Oligometastatic Non-Small Cell Lung Cancer
Overall registry status Completed
Phase 2
Conditions Oligometastatic Non-small Cell Lung Cancer (NSCLC)
Delaware Valley sites
- Abramson Cancer Center of the University of Pennsylvania · Philadelphia, PA · Philadelphia County
First posted
Registry updated
Added to the directory